全文获取类型
收费全文 | 15622篇 |
免费 | 1072篇 |
国内免费 | 228篇 |
专业分类
耳鼻咽喉 | 158篇 |
儿科学 | 738篇 |
妇产科学 | 111篇 |
基础医学 | 754篇 |
口腔科学 | 119篇 |
临床医学 | 3432篇 |
内科学 | 2418篇 |
皮肤病学 | 49篇 |
神经病学 | 347篇 |
特种医学 | 502篇 |
外国民族医学 | 4篇 |
外科学 | 2388篇 |
综合类 | 2645篇 |
预防医学 | 1123篇 |
眼科学 | 66篇 |
药学 | 1294篇 |
16篇 | |
中国医学 | 260篇 |
肿瘤学 | 498篇 |
出版年
2024年 | 10篇 |
2023年 | 254篇 |
2022年 | 378篇 |
2021年 | 648篇 |
2020年 | 660篇 |
2019年 | 574篇 |
2018年 | 571篇 |
2017年 | 592篇 |
2016年 | 607篇 |
2015年 | 509篇 |
2014年 | 1111篇 |
2013年 | 1027篇 |
2012年 | 990篇 |
2011年 | 1079篇 |
2010年 | 838篇 |
2009年 | 807篇 |
2008年 | 734篇 |
2007年 | 759篇 |
2006年 | 688篇 |
2005年 | 623篇 |
2004年 | 467篇 |
2003年 | 363篇 |
2002年 | 270篇 |
2001年 | 241篇 |
2000年 | 201篇 |
1999年 | 198篇 |
1998年 | 140篇 |
1997年 | 127篇 |
1996年 | 149篇 |
1995年 | 155篇 |
1994年 | 112篇 |
1993年 | 96篇 |
1992年 | 103篇 |
1991年 | 75篇 |
1990年 | 104篇 |
1989年 | 90篇 |
1988年 | 58篇 |
1987年 | 66篇 |
1986年 | 52篇 |
1985年 | 71篇 |
1984年 | 79篇 |
1983年 | 39篇 |
1982年 | 49篇 |
1981年 | 28篇 |
1980年 | 37篇 |
1979年 | 24篇 |
1978年 | 16篇 |
1977年 | 20篇 |
1976年 | 11篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 144 毫秒
1.
目的:分析子野个数限值对宫颈癌固定野调强放疗(fixed-field intensity-modulated radiotherapy,ff-IMRT)计划的影响,寻求最优的子野个数限值。方法:选取10例接受ff-IMRT的宫颈癌患者,基于Monaco 5.11.03计划系统,以45 Gy/25 f处方剂量分别对同一患者设计8种ff-IMRT计划(ff-IMRT计划依据子野个数限值命名,子野个数限值分别为40、60、70、80、100、120、130、150),采用SPSS 20.0软件比较除plan100之外7个ff-IMRT计划与plan100剂量学参数、优化时间和治疗参数的差异。结果:8种ff-IMRT计划归一化后,plan40和plan60的D2%、Dmin、CI和HI均劣于plan100(P<0.05)。8种ff-IMRT计划均能较好保护危及器官(organ at risk,OAR)和正常组织。plan40小肠V45;plan40和plan60小肠D2cc,直肠、膀胱V45、D40%,两侧股骨头V40和正常组织 V35、V40均高于plan100(P<0.05)。plan40和plan60优化时间、治疗参数均优于plan100(P<0.05);plan120、plan130和plan150子野面积、子野个数(51~150 cm2和>150 cm2)和出束时间均劣于plan100(P<0.05)。结论:子野个数限值为70~100时,ff-IMRT计划能兼顾剂量学参数满足临床要求、优化时间和治疗参数最优化,建议在设计宫颈癌ff-IMRT计划时在该范围内设置子野个数限值。 相似文献
2.
3.
4.
5.
《Advances in medical sciences》2021,66(2):388-395
Electrical impedance tomography (EIT) is a non-invasive, radiation-free method of diagnostics imaging, allowing for a bedside, real-time dynamic assessment of lung function. It stands as an alternative for other imagining methods, such as computed tomography (CT) or ultrasound. Even though the technique is rather novel, it has a wide variety of possible applications. In the era of modern mechanical ventilation, a dynamic assessment of patient's respiratory condition appears to fulfil the idea of personalized treatment. Additionally, an increasing frequency of respiratory failure among intensive care populations raises demand for improved monitoring tools. This review aims to raise awareness and presents possible implications for the use of EIT in the intensive care setting. 相似文献
6.
7.
《Vaccine》2021,39(45):6601-6613
AKS-452 is a biologically-engineered vaccine comprising an Fc fusion protein of the SARS-CoV-2 viral spike protein receptor binding domain antigen (Ag) and human IgG1 Fc (SP/RBD-Fc) in clinical development for the induction and augmentation of neutralizing IgG titers against SARS-CoV-2 viral infection to address the COVID-19 pandemic. The Fc moiety is designed to enhance immunogenicity by increasing uptake via Fc-receptors (FcγR) on Ag-presenting cells (APCs) and prolonging exposure due to neonatal Fc receptor (FcRn) recycling. AKS-452 induced approximately 20-fold greater neutralizing IgG titers in mice relative to those induced by SP/RBD without the Fc moiety and induced comparable long-term neutralizing titers with a single dose vs. two doses. To further enhance immunogenicity, AKS-452 was evaluated in formulations containing a panel of adjuvants in which the water-in-oil adjuvant, Montanide™ ISA 720, enhanced neutralizing IgG titers by approximately 7-fold after one and two doses in mice, including the neutralization of live SARS-CoV-2 virus infection of VERO-E6 cells. Furthermore, ISA 720-adjuvanted AKS-452 was immunogenic in rabbits and non-human primates (NHPs) and protected from infection and clinical symptoms with live SARS-CoV-2 virus in NHPs (USA-WA1/2020 viral strain) and the K18 human ACE2-trangenic (K18-huACE2-Tg) mouse (South African B.1.351 viral variant). These preclinical studies support the initiation of Phase I clinical studies with adjuvanted AKS-452 with the expectation that this room-temperature stable, Fc-fusion subunit vaccine can be rapidly and inexpensively manufactured to provide billions of doses per year especially in regions where the cold-chain is difficult to maintain. 相似文献
8.
《Pancreatology》2022,22(5):665-670
Background and objectivesHyperlipasemia is highly prevalent among coronavirus disease 2019 (COVID-19) patients. The aim of this study was to assess the effect of lipase activity, measured at the time of admission, on the clinical course and mortality in COVID-19 patients.MethodsThe population of this study comprised 12,139 patients who were hospitalized due to COVID-19 between June 2020 and June 2021 in a pandemic hospital. Of these, 8819 patients were excluded from the study due to missing data, four patients were excluded due to a diagnosis of acute pancreatitis (according to the revised Atlanta criteria), and 72 patients were excluded due to alcohol use or having a history of chronic pancreatitis. The final study sample consisted of the remaining 3244 COVID-19 patients. Laboratory results, intensive care unit (ICU) follow-up periods, the need for mechanical ventilation, and mortality rates were compared between the normal lipase activity and high lipase activity groups.ResultsThere were 968 (29.8%) patients with high lipase activity at the time of admission. The rate of ICU admission was 36.1% vs. 9.9% (p < 0.001), mechanical ventilation requirement rates were 33.7% vs. 8.3% (p < 0.001), and mortality rates were as 24.6% vs. 6.4% (p < 0.001) in the high lipase activity group compared to the normal lipase activity group. Multivariate regression analysis revealed that high lipase activity was an independent factor in predicting mortality in hospitalized COVID-19 patients (odds ratio [OR]: 3.191, p < 0.001).ConclusionElevated lipase activity without acute pancreatitis at the time of admission in COVID-19 patients was determined as an independent predictor of poor prognosis. 相似文献
9.
10.
Peter H. Egbers Anna-Liisa Sutt Jenny E. Petersson Liza Bergström Eva Sundman 《Acta anaesthesiologica Scandinavica》2023,67(10):1403-1413